Loading…
ADHEROZA is a brand name for Trastuzumab, supplied as a powder for solution. The medicine, its uses, side effects and dosage are the same regardless of brand.
Verbatim from this product's HC label. Tap a section to expand.
3 Reconstitution 2025-11 7 WARNINGS AND PRECAUTIONS 2025-11 Table of Contents Certain sections or subsections that are not applicable at the time of the preparation of the most recent authorized product monograph are not listed. 1 Pediatrics .................................................................................................................
2 Geriatrics ................................................................................................................. 1 Dosing Considerations .............................................................................................
2 Recommended Dose and Dosage Adjustment ........................................................ 3 Reconstitution ....................................................................................................... 4 Administration .......................................................................................................
5 Missed Dose .......................................................................................................... 16 General............................................................................................................................
16 Cardiovascular ................................................................................................................. 16 Driving and Operating Machinery ...................................................................................
26 Hematologic .................................................................................................................... 26 Immune ...........................................................................................................................
27 Reproductive Health ............................................................................................................... 29 ADHEROZA – trastuzumab for injection Page 3 of 132 Repsiratory ..........................................................................
Error! Bookmark not defined. 1 Special Populations................................................................................................ 1 Pregnancy ........................................................................................................
2 Breastfeeding .................................................................................................. 3 Pediatrics .........................................................................................................
4 Geriatrics ......................................................................................................... 30 8 Adverse Reactions ................................................................... Error! Bookmark not defined.
1 Adverse Reaction Overview ................................................................................... 2 Clinical Trial Adverse Reactions ............................................................................. 3 Less Common Clinical Trial Adverse Reactions ......................................................
2025-11 Table of Contents Certain sections or subsections that are not applicable at the time of the preparation of the most recent authorized product monograph are not listed. 1 Pediatrics .................................................................................................................
2 Geriatrics ................................................................................................................. 1 Dosing Considerations .............................................................................................
2 Recommended Dose and Dosage Adjustment ........................................................ 3 Reconstitution ....................................................................................................... 4 Administration .......................................................................................................
5 Missed Dose .......................................................................................................... 16 General............................................................................................................................
16 Cardiovascular ................................................................................................................. 16 Driving and Operating Machinery ...................................................................................
26 Hematologic .................................................................................................................... 26 Immune ...........................................................................................................................
27 Reproductive Health ............................................................................................................... 29 ADHEROZA – trastuzumab for injection Page 3 of 132 Repsiratory ..........................................................................
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Trastuzumab in Canada.
Know a brand we are missing in Canada? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
4 Abnormal Laboratory Findings: Hematologic, Clinical Chemistry, and Other Quantitative Data ............................................................................................................ 5 Post-Market Adverse Reactions ............................................................................
2 Drug Interactions Overview ................................................................................... 3 Drug-Behaviour Interactions ................................................................................. 4 Drug-Drug Interactions ..........................................................................................
5 Drug-Food Interactions.......................................................................................... 6 Drug-Herb Interactions .......................................................................................... 7 Drug-Laboratory Test Interactions.........................................................................
1 Mechanism of Action............................................................................................. 2 Pharmacodynamics ............................................................................................... 3 Pharmacokinetics […]
Error! Bookmark not defined. 1 Special Populations................................................................................................ 1 Pregnancy ........................................................................................................
2 Breastfeeding .................................................................................................. 3 Pediatrics .........................................................................................................
4 Geriatrics ......................................................................................................... 30 8 Adverse Reactions ................................................................... Error! Bookmark not defined.
1 Adverse Reaction Overview ................................................................................... 2 Clinical Trial Adverse Reactions ............................................................................. 3 Less Common Clinical Trial Adverse Reactions ......................................................
4 Abnormal Laboratory Findings: Hematologic, Clinical Chemistry, and Other Quantitative Data ............................................................................................................ 5 Post-Market Adverse Reactions ............................................................................
2 Drug Interactions Overview ................................................................................... 3 Drug-Behaviour Interactions ................................................................................. 4 Drug-Drug Interactions ..........................................................................................
5 Drug-Food Interactions.......................................................................................... 6 Drug-Herb Interactions .......................................................................................... 7 Drug-Laboratory Test Interactions.........................................................................
1 Mechanism of Action............................................................................................. 2 Pharmacodynamics ............................................................................................... 3 Pharmacokinetics […]